Laura Williams
Fortune : 2 M $ au 31/07/2026
Fortune : 2 M $ au 31/07/2026
Laura A. Williams is Chief Patient Officer at Ardelyx, Inc. since 2025.
Formerly, Dr. Williams was Independent Director at Imara, Inc. from 2021 to 2023, Senior Vice President-Clinical Development at AMAG Pharmaceuticals, Inc. from 2017 to 2020, and Vice President-Clinical Development at Myovant Sciences, Inc. from 2016 to 2017.
Education includes graduate studies at the University of Washington, undergraduate studies at Mississippi State University, and a doctorate from the University of Iowa.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,15 % | 18/06/2026 | 378 195 ( 0,15 % ) | 2 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Corporate Officer/Principal | 01/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| IMARA | Directeur/Membre du Conseil | 01/02/2023 |
| AMAG PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Directeur Technique/Scientifique/R&D | 01/08/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mississippi State University
Mississippi State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Imara, Inc.
Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national